Metabolic Research
Creative Biolabs has the assays you can rely on for high throughput screening, lead optimization, characterizing and discovering targets, and uncovering the complexity of disease pathways. We can offer membrane protein in vitro assay kits that save valuable laboratory time and is ideal for high throughput screening.
Membrane protein stable cell lines are widely used in many areas of biomedical research. Creative Biolabs can offer membrane protein stable cell lines to stablish in vitro models for High Throughput Screening.
Creative Biolabs offers high-quality, innovative tools to help research groups accelerate membrane protein drug discovery. They can be found by targets. If there is no product that meets your needs, please contact us.
Metabolic disorders are a type of disease that affects metabolism. Metabolism is the process that the body uses to convert food into energy. If this process does not work correctly, it can cause problems with a person's health. Metabolic disorders can be caused by problems with how the body breaks down food, how the body uses energy, or how the body makes or uses certain enzymes. They can also be caused by problems with certain hormones or proteins in the cell membranes. Metabolic disorders can lead to obesity, diabetes, and heart disease. There are many different types of metabolic disorders, and various factors can cause them. Treatment for metabolic disorders depends on the specific disorder but may include diets, exercise, and medication.
Metabolic Disorders and Related Membrane Proteins
- Metabolic syndrome X
Metabolic syndrome X (MSX) is a metabolic disorder characterized by insulin resistance, hypertension, and increased LDL cholesterol and triglyceride levels. The exact cause of metabolic syndrome X is unknown, but it is thought to be associated with obesity, a sedentary lifestyle, and genetics. The disorder can lead to type 2 diabetes, heart disease, and stroke.
Until now, there is no cure for this condition. Treatment focuses on managing the symptoms. One potential treatment target is a membrane protein called ABCA1 (ATP-Binding Cassette transporter A1). This protein help to regulate lipid metabolism and is deficient in patients with metabolic syndrome X. By targeting this protein, it may be possible to improve lipid metabolism and reduce the symptoms of this condition. However, more research is needed to determine the efficacy of this treatment approach.
Fig.1 ABCA1 functions in different cell types and associated diseases.1,2
- Acid-Base Imbalance
Acid-base imbalance is a condition that can lead to several serious health problems. There are many causes of acid imbalance, but the most common is an electrolyte imbalance. When the body's acid-base balance is out of alignment, it can cause several symptoms, including fatigue, muscle weakness, and respiratory problems. Acid-base imbalance can also lead to more severe conditions like heart disease and kidney disease
Some treatments can help to alleviate the symptoms and improve the quality of life for those affected by this condition. One promising area of research is the targeting of membrane proteins. Sodium-hydrogen exchangers (NHEs) are a family of membrane proteins that play a crucial role in regulating acid-base balance. NHE3 is one of the essential NHEs responsible for sodium reabsorption in the kidney. Inhibiting NHE3 has been shown to be an effective treatment for acid-base imbalance and can help prevent serious health complications.
- Lipid Metabolism Disorders
Lipid metabolism disorders are a group of conditions that affect the body's ability to produce or process Lipids. Lipids are a fat essential for the body's function. Lipids are used to build cell membranes, make hormones, and absorb vitamins. Lipids are also a source of energy. Lipid metabolism disorders can cause various symptoms, including liver enlargement, fatty liver disease, deficiency in specific vitamins and minerals, and problems with blood clotting. In severe cases, Lipid metabolism disorders can be life-threatening.
One potential remedy for Lipid metabolism disorders is targeting TMEM24 (Transmembrane Protein 24). TMEM24 is a transmembrane protein that is involved in the transport of Lipids. Mutations in the TMEM24 gene have been linked to Lipid metabolism disorders. Some studies have shown that targeting TMEM24 can help to reduce lipid levels and improve Lipid metabolism in patients with Lipid metabolism disorders.
References
- Jacobo-Albavera, Leonor, et al. "The role of the ATP-binding cassette A1 (ABCA1) in human disease." International journal of molecular sciences 22.4 (2021): 1593.
- Image retrieved from Figure 1 " ATP-binding cassette transporter A1 (ABCA1) functions in different cell types and associated diseases. " Jacobo-Albavera, et al. 2021, used under CC BY 4.0. The original image was modified by extracting and the title was changed to " ABCA1 functions in different cell types and associated diseases.".
